241 related articles for article (PubMed ID: 23077404)
1. Bevacizumab and intraocular tumors: an intriguing paradox.
el Filali M; Ly LV; Luyten GP; Versluis M; Grossniklaus HE; van der Velden PA; Jager MJ
Mol Vis; 2012; 18():2454-67. PubMed ID: 23077404
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.
Yang H; Jager MJ; Grossniklaus HE
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2835-42. PubMed ID: 20089875
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A
Oncotarget; 2016 Feb; 7(7):7816-28. PubMed ID: 26761211
[TBL] [Abstract][Full Text] [Related]
4. Regulation of VEGF-A in uveal melanoma.
el Filali M; Missotten GS; Maat W; Ly LV; Luyten GP; van der Velden PA; Jager MJ
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2329-37. PubMed ID: 20042655
[TBL] [Abstract][Full Text] [Related]
5. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
[TBL] [Abstract][Full Text] [Related]
6. Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical study.
Sudaka A; Susini A; Lo Nigro C; Fischel JL; Toussan N; Formento P; Tonissi F; Lattanzio L; Russi E; Etienne-Grimaldi MC; Merlano M; Milano G
Invest New Drugs; 2013 Feb; 31(1):59-65. PubMed ID: 22714791
[TBL] [Abstract][Full Text] [Related]
7. Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.
Higashide T; Murotani E; Saito Y; Ohkubo S; Sugiyama K
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):603-10. PubMed ID: 22116499
[TBL] [Abstract][Full Text] [Related]
8. Autocrine impact of VEGF-A on uveal melanoma cells.
Koch KR; Refaian N; Hos D; Schlereth SL; Bosch JJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2697-704. PubMed ID: 24677103
[TBL] [Abstract][Full Text] [Related]
9. Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.
Dong L; You S; Zhang Q; Osuka S; Devi NS; Kaluz S; Ferguson JH; Yang H; Chen G; Wang B; Grossniklaus HE; Van Meir EG
Clin Cancer Res; 2019 Apr; 25(7):2206-2218. PubMed ID: 30563937
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.
Sharma RK; Balaiya S; Chalam KV
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6906; author reply 6906-7. PubMed ID: 21123801
[No Abstract] [Full Text] [Related]
11. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
Kim YJ; Lee HJ; Kim TM; Eisinger-Mathason TS; Zhang AY; Schmidt B; Karl DL; Nakazawa MS; Park PJ; Simon MC; Yoon SS
Int J Cancer; 2013 Jan; 132(1):29-41. PubMed ID: 22684860
[TBL] [Abstract][Full Text] [Related]
12. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.
Melstrom LG; Salabat MR; Ding XZ; Strouch MJ; Grippo PJ; Mirzoeva S; Pelling JC; Bentrem DJ
J Surg Res; 2011 May; 167(2):173-81. PubMed ID: 21227456
[TBL] [Abstract][Full Text] [Related]
13. [Combination with SN-38 on human colon cancer LoVo cells].
Wang Y; Xu JM; Xu QZ; Zhou PK; Song ST
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):746-851. PubMed ID: 20021826
[TBL] [Abstract][Full Text] [Related]
14. Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model.
Yang H; Akor C; Dithmar S; Grossniklaus HE
Mol Vis; 2004 Dec; 10():987-95. PubMed ID: 15623988
[TBL] [Abstract][Full Text] [Related]
15. Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.
El Filali M; Homminga I; Maat W; van der Velden PA; Jager MJ
Mol Vis; 2008 Sep; 14():1752-9. PubMed ID: 18836566
[TBL] [Abstract][Full Text] [Related]
16. Vernolide-A inhibits radiation-induced hypoxia-mediated tumor angiogenesis by regulating HIF-1α, MMP-2, MMP-9, and VEGF.
Pratheeshkumar P; Kuttan G
J Environ Pathol Toxicol Oncol; 2011; 30(2):139-51. PubMed ID: 21967458
[TBL] [Abstract][Full Text] [Related]
17. The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.
Adamcic U; Skowronski K; Peters C; Morrison J; Coomber BL
Neoplasia; 2012 Jul; 14(7):612-23. PubMed ID: 22904678
[TBL] [Abstract][Full Text] [Related]
18. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
19. Role of IL-8 induced angiogenesis in uveal melanoma.
Lattanzio L; Tonissi F; Torta I; Gianello L; Russi E; Milano G; Merlano M; Lo Nigro C
Invest New Drugs; 2013 Oct; 31(5):1107-14. PubMed ID: 23912257
[TBL] [Abstract][Full Text] [Related]
20. Efficient inhibition of uveal melanoma via ternary siRNA complexes.
Xie L; Yang Y; Shen J
Int J Pharm; 2020 Jan; 573():118894. PubMed ID: 31765784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
